West to Participate in Upcoming Investor Conferences
West Pharmaceutical Services (NYSE: WST), a leader in injectable drug administration solutions, has announced its participation in two upcoming investor conferences in March 2025:
- The Barclays 27th Annual Global Healthcare Conference on March 12, 2025, at 11:00 AM ET
- The KBCM Healthcare Forum on March 19, 2025, at 1:30 PM ET
Both presentations will be accessible via live audio webcast through the company's website investor section. Interested parties can access replays of the presentations for approximately 90 days following the events.
West Pharmaceutical Services (NYSE: WST), leader nelle soluzioni per la somministrazione di farmaci iniettabili, ha annunciato la sua partecipazione a due conferenze per investitori che si terranno a marzo 2025:
- La 27ª Conferenza Globale Annuale sulla Salute di Barclays il 12 marzo 2025, alle 11:00 ET
- Il Forum Sanitario KBCM il 19 marzo 2025, alle 13:30 ET
Entrambe le presentazioni saranno disponibili tramite webcast audio dal vivo nella sezione investitori del sito web dell'azienda. Le parti interessate potranno accedere alle registrazioni delle presentazioni per circa 90 giorni dopo gli eventi.
West Pharmaceutical Services (NYSE: WST), líder en soluciones para la administración de medicamentos inyectables, ha anunciado su participación en dos conferencias para inversores que se llevarán a cabo en marzo de 2025:
- La 27ª Conferencia Global Anual de Salud de Barclays el 12 de marzo de 2025, a las 11:00 AM ET
- El Foro de Salud KBCM el 19 de marzo de 2025, a la 1:30 PM ET
Ambas presentaciones estarán disponibles a través de una transmisión de audio en vivo en la sección de inversores del sitio web de la empresa. Las partes interesadas podrán acceder a las grabaciones de las presentaciones durante aproximadamente 90 días después de los eventos.
웨스트 제약 서비스 (NYSE: WST), 주사 약물 투여 솔루션의 선두주자가 2025년 3월에 열리는 두 개의 투자자 회의에 참여한다고 발표했습니다:
- 바클레이즈 제27회 연례 글로벌 헬스케어 컨퍼런스가 2025년 3월 12일 오전 11시(ET)에 열립니다.
- KBCM 헬스케어 포럼이 2025년 3월 19일 오후 1시 30분(ET)에 열립니다.
두 프레젠테이션 모두 회사 웹사이트의 투자자 섹션을 통해 실시간 오디오 웹캐스트로 제공됩니다. 관심 있는 분들은 이벤트 후 약 90일 동안 프레젠테이션 재생을 이용할 수 있습니다.
West Pharmaceutical Services (NYSE: WST), un leader dans les solutions d'administration de médicaments injectables, a annoncé sa participation à deux conférences pour investisseurs à venir en mars 2025 :
- La 27e Conférence Annuelle Mondiale sur la Santé de Barclays le 12 mars 2025, à 11h00 ET
- Le Forum de Santé KBCM le 19 mars 2025, à 13h30 ET
Les deux présentations seront accessibles via un webcast audio en direct dans la section investisseurs du site web de l'entreprise. Les parties intéressées pourront accéder aux rediffusions des présentations pendant environ 90 jours après les événements.
West Pharmaceutical Services (NYSE: WST), ein führendes Unternehmen im Bereich der Injektionsmedikamentenlösungen, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im März 2025 angekündigt:
- Die 27. Barclays Globale Gesundheitskonferenz am 12. März 2025 um 11:00 Uhr ET
- Das KBCM Gesundheitsforum am 19. März 2025 um 13:30 Uhr ET
Beide Präsentationen werden über einen Live-Audio-Webcast im Investorenbereich der Unternehmenswebsite zugänglich sein. Interessierte Parteien können die Aufzeichnungen der Präsentationen etwa 90 Tage nach den Veranstaltungen abrufen.
- None.
- None.
It will also present at the KBCM Healthcare Forum on Wednesday, March 19, 2025 at 1:30 PM ET.
A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conferences-302391890.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
When is West Pharmaceutical Services (WST) presenting at the Barclays Healthcare Conference 2025?
How long will the WST investor conference webcasts be available for replay?
Where can investors access West Pharmaceutical Services' March 2025 conference presentations?
What time is West Pharmaceutical Services (WST) presenting at the KBCM Healthcare Forum?
